Sargent Investment Group’s Niagen Bioscience NAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.2K	Hold	15,000	–	–	0.01%	262
2025 Q4	$95.4K	Sell	15,000 -20,002	-57%	-$139K	0.01%	253
2025 Q3	$327K	Sell	35,002 -14,998	-30%	-$151K	0.05%	107
2025 Q2	$470K	Hold	50,000	–	–	0.06%	159
2025 Q1	$345K	Hold	50,000	–	–	0.06%	177
2024 Q4	$263K	Buy	+50,000	New	+$274K	0.04%	199
2022 Q3	–	Sell	-16,000	Closed	-$27K	–	200
2022 Q2	$27K	Hold	16,000	–	–	0.01%	184
2022 Q1	$39K	Hold	16,000	–	–	0.01%	188
2021 Q4	$60K	Sell	16,000 -5,000	-24%	-$27K	0.01%	181
2021 Q3	$132K	Buy	21,000 +1,000	+5%	+$8.24K	0.03%	181
2021 Q2	$197K	Hold	20,000	–	–	0.05%	190
2021 Q1	$187K	Hold	20,000	–	–	0.05%	183
2020 Q4	$96K	Sell	20,000 -5,000	-20%	-$24.4K	0.03%	176
2020 Q3	$100K	Buy	25,000 +13,000	+108%	+$62.7K	0.04%	157
2020 Q2	$54K	Sell	12,000 -82,000	-87%	-$367K	0.02%	146
2020 Q1	$306K	Buy	94,000 +82,000	+683%	+$315K	0.14%	110
2019 Q4	$52K	Buy	+12,000	New	+$42.6K	0.02%	152
2019 Q3	–	Sell	-102,000	Closed	-$474K	–	154
2019 Q2	$474K	Sell	102,000 -1,500	-1%	-$6.4K	0.22%	88
2019 Q1	$434K	Hold	103,500	–	–	0.21%	87
2018 Q4	$355K	Buy	+103,500	New	+$360K	0.22%	87